medigraphic.com
A partir del año 2010, la Revista Oficial del INER cambió a NCT (Neumología y Cirugía de Tórax)

 Ver actualización

2005, Number 3

<< Back Next >>

Rev Inst Nal Enf Resp Mex 2005; 18 (3)

Use of glutaraldehide-treated bovine pericardium

Pérez CD, Sotres VA, Jasso VR, Olmos ZJR, Villalba CJ, Santibáñez SJA, Santillán DP

Language: Spanish
References: 46
Page: 224-229
PDF size: 61.33 Kb.


ABSTRACT

The use of biological and mechanical prostheses arose from the need to replace a failing organ or function. Bioprostheses can be manufactured from autologous, homologus or heterologus tissue; glutaraldehyde treated bovine pericardium bioprostheses have been used extensively to repair diaphragmatic, abdominal and chest wall defects and to replace heart valves, blood vessels and tracheal segments, but the implanted tissue can elicit rejection or foreign body reaction; these have been extensively studied in order to avoid them. We review the literature regarding glutaraldehyde treated bovine pericardium bioprostheses.


REFERENCES

  1. Holt JP. The normal pericardium. Am J Cardiol 1970;26:455-465.

  2. Elias H, Boyd LJ. Notes on the anatomy, embryology, and histology of the pericardium. II. N Y Med Coll News Notes 1960;2:50-75.

  3. Ishihara T, Ferrans VJ, Jones M, Boyce SW, Kawanami O, Roberts WC. Histologic and ultrastructural features of normal human parietal pericardium. Am J Cardiol 1980;46:744-753.

  4. Santibáñez-Salgado JA. Tratamiento quirúrgico de hernias postincisionales con pericardio de bovino tratado con glutaraldehído (tesis). México, DF: UNAM; 1993.

  5. Santillan-Doherty P, Jasso-Victoria R, Sotres-Vega A, et al. Thoracoabdominal wall repair with glutaraldehyde-preserved bovine pericardium. J Invest Surg 1996;9:45-55.

  6. Smith DJ Jr, Jones CS, Hull M, Robson MC, Kleinert HE. Bioprostheses in hand surgery. J Surg Res 1986; 41:378-387.

  7. Hellstrom WJ, Reddy S. Application of pericardial graft in the surgical management of Peyronie’s disease. J Urol 2000;163:1445-1447.

  8. Pais VM Jr, Jiang Z, Fung LC. Foreign-body reaction to bovine pericardium: a previously unreported complication of pediatric chordee repair. J Urol 2002;168:702-703.

  9. Olmos-Zúñiga JR, Jasso-Victoria R, Sotres-Vega A, et al. Utilización de pericardio bovino tratado con glutaraldehído liofilizado en la reparación de defectos abdominales en ratas. Cir Gen 1996;18:161-165.

  10. Rey A. Hernioplastía ventral infraumbilical en equino con pericardio de bovino tratado con glutaraldehído. Reporte de un caso. Memorias del Primer Congreso Nacional de Cirugía Veterinaria. México, DF: UNAM;1990.

  11. Reyes F. Hernioplastía ventral en caninos con bioprótesis de pericardio bovino tratado con glutaraldehído (tesis). México, DF: UNAM;1990.

  12. Santillán-Doherty P, Jasso-Victoria R, Sotres-Vega A, et al. Reparación de defectos de pared toracoabdominal de perros con bioprótesis de pericardio bovino. Rev Invest Clin 1995;47:439-449.

  13. Olmos-Zúñiga JR. Estudio funcional y microestructural de bioprótesis de pericardio bovino tratado con glutaraldehído en diafragma de perros (tesis). México, DF: UNAM;1990.

  14. Gallo JI, Artiñano E, Val F, Duran CG. Glutaraldehyde-preserved heterologous pericardium for the repair of diaphragmatic defects: experimental study. J Thorac Cardiovasc Surg 1982;83:905-908.

  15. Boin I de F, Joaquim JL, Leonardi LS. Glutaraldehyde-preserved bovine pericardium for the repair of diaphragmatic defects due to extensive metastatic liver resection. Hepatogastroenterology 2003;50:839-840.

  16. Jasso-Victoria R, Olmos-Zúñiga JR, Arreola-Ramírez JL, Sotres-Vega A, Vanda-Cantón B, Santillán-Doherty P. Reconstrucción del esternón con pericardio bovino tratado con glutaraldehído (PBTG). Estudio experimental. Rev Inst Nal Enf Resp Méx. 1995;8:189-191.

  17. Olmos-Zúñiga JR, Jasso-Victoria R, Sotres-Vega A, et al. Evaluación de la utilidad del pericardio bovino en resecciones pulmonares no anatómicas en perros. Rev Invest Clin 2002;54:334-341.

  18. Binet JP, Planche C, Weiss M. Heterograft replacement of the aortic valve. In: Ionescu MI, Ross DN, Wooler GH, editors. Biological tissue in heart valve replacement. London: Butterworths; 1972.p.515-541.

  19. Carpentier A, Lemaigre G, Robert L, Carpentier S, Dubost C. Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg 1969;58:467-483.

  20. Carpentier A, Deloche A, Relland J, et al. Six-year follow-up of glutaraldehyde-preserved heterografts. With particular reference to the treatment of congenital valve malformations. J Thorac Cardiovasc Surg 1974;68:771-782.

  21. Schoen FJ, Hobson CE. Anatomic analysis of removed prosthetic heart valves: causes of failure of 33 mechanical valves and 58 bioprostheses, 1980 to 1983. Hum Pathol 1985;16:549-559.

  22. Schoen FJ, Titus JL, Lawrie GM. Autopsy-determined causes of death after cardiac valve replacement. JAMA 1983;249:899-902.

  23. Roberts WC. Factors determining outcome of cardiac valve replacement. Ann Thorac Surg 1979;27:101-103.

  24. Schoen FJ, Fernandez J, Gonzalez-Lavin L, Cernaianu A. Causes of failure and pathological findings in surgically removed Ionescu-Shiley standard bovine pericardial heart valve bioprostheses: emphasis on progressive structural deterioration. Circulation 1987;76:618-627.

  25. Schoen FJ, Levy RJ. Bioprosthetic heart valve failure: pathology and pathogenesis. Cardiol Clin 1984;2:717-739.

  26. Schoen FJ, Tsao JW, Levy RJ. Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for the mechanisms of bioprosthetic tissue mineralization. Am J Pathol 1986;123:134-145.

  27. Fischbein MC, Levy RJ, Ferrans VJ, et al. Calcifications of cardiac valve bioprostheses. Biochemical, histologic, and ultrastructural observations in subcutaneous implantation model system. J Thorac Cardiovasc Surg 1982;83:602-609.

  28. Ferrans VJ, Boyce SW, Billingham ME, Jones M, Ishihara T, Roberts WC. Calcific deposits in porcine bioprostheses: structure and pathogenesis. Am J Cardiol 1980;46:721-734.

  29. Valente M, Bortolotti U, Thiene G. Ultrastructural substrates of dystrophic calcification in porcine bioprosthetic valve failure. Am J Pathol 1985;119:12-21.

  30. Schoen FJ, Levy RJ, Nelson AC, Bernhard WF, Nashef A, Hawley M. Onset and progression of experimental bioprosthetic heart-valve calcification. Lab Invest 1985;52:523-532.

  31. Harasaki H, McMahon J, Richards T, Goldcamp J, Kiraly R, Nose Y. Calcification in cardiovascular implants: degraded cell-related phenomena. Trans Am Soc Artif Intern Organs 1985;31:489-494.

  32. Levy RJ, Schoen FJ, Flowers WB, Staelin ST. Initiation of mineralization in bioprosthetic heart valve: studies of alkaline phosphatase activity and its inhibition by AlCl3 or FeCl3 pre-incubations. J Biomed Mater Res 1991;25:905-935.

  33. Maranto AR, Schoen FJ. Alkaline phosphatase activity of glutaraldehyde-treated bovine pericardium used in bioprosthetic cardiac valve. Circ Res 1988;63:844-848.

  34. Levy RJ, Schoen FJ, Golomb G. Bioprosthetic heart valve calcification: clinical features, pathobiology and prospects for prevention. CRC Crit Rev Biocompat 1986;2:147-187.

  35. Fishbein MC, Levy RJ, Ferrans VJ, et al. Calcification of cardiac valve bioprostheses. Biochemical, histologic, and ultrastructural observations in a subcutaneous implantation model system. J Thorac Cardiovasc Surg 1982;83:602-609.

  36. Levy RJ, Schoen FJ, Levy JT, Nelson AC, Howard SL, Oshry LJ. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol 1983;113:143-155.

  37. Golomb G, Schoen FJ, Smith MS, Linden J, Dixon M, Levy RJ. The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses. Am J Pathol 1987;127:122-130.

  38. Vasudev SC, Chandy T, Umasankar MM, Sharma CP. Inhibition of bioprosthesis calcification due to synergistic effect of Fe/Mg ions to polyethylene glycol grafted bovine pericardium. J Biomater Appl 2001;16:93-107.

  39. Golomb G. Controlled release of diphosphonates from synthetic polymers to inhibit calcification. J Biomater Appl 1987;2:266-289.

  40. Chandy T, Mohanty M, John A, et al. Structural studies on bovine bioprosthetic tissues and their in vivo calcification: prevention via drug delivery. Biomaterials 1996;17:577-585.

  41. Webb CL, Schoen FJ, Flowers WE, Alfrey AC, Horton C, Levy RJ. Inhibition of mineralization of glutaraldehyde-pretreated bovine pericardium by AlCl3. Mechanisms and comparisons with FeCl3, LaCl3 and Ga(NO3)3 in rat subdermal model studies. Am J Pathol 1991;138:971-981.

  42. Fitzgibbons RJ Jr, Greenburg AG, Nyhus LM. Nyhus and condon´s hernia. 5th ed. Philadelphia, USA: Lippincot and Wilkins;1989.

  43. Schwartz DI, Ellis H. Maingot’s abdominal operations. 9th ed. Norwalk, Connecticut, USA: Appleton & Lange;1989.

  44. Skandalakis JE, Gray DW, Mansberger AR, et al. Hernia: surgical anatomy and technique. Singapore: Mc Graw-Hill;1989.

  45. Sher W, Pollack D, Paulides CA, Matsumoto T. Repair of abdominal wall defects: Gore-Tex vs Marlex graft. Am Surg 1980;46:618-623.

  46. Arreola-Ramírez JL. Utilización del pericardio bovino como sustituto de tráquea (tesis). México, DF: UNAM;1990.




2020     |     www.medigraphic.com